Chemoinformaics analysis of 3,5-Dimethyl-2-(1-propenyl)pyrazine
Molecular Weight | 148.209 | nRot | 1 |
Heavy Atom Molecular Weight | 136.113 | nRig | 7 |
Exact Molecular Weight | 148.1 | nRing | 1 |
Solubility: LogS | -4.268 | nHRing | 1 |
Solubility: LogP | 3.418 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 25.2315 |
nHD | 0 | BPOL | 14.3185 |
QED | 0.622 |
Synth | 2.88 |
Natural Product Likeliness | -0.162 |
NR-PPAR-gamma | 0.104 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.366 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.371 |
MDCK | 0.0000404 |
BBB | 0.996 |
PPB | 0.933073 |
VDSS | 1.434 |
FU | 0.118777 |
CYP1A2-inh | 0.772 |
CYP1A2-sub | 0.872 |
CYP2c19-inh | 0.834 |
CYP2c19-sub | 0.85 |
CYP2c9-inh | 0.85 |
CYP2c9-sub | 0.685 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.379 |
CYP3a4-inh | 0.18 |
CYP3a4-sub | 0.908 |
CL | 2.122 |
T12 | 0.071 |
hERG | 0.051 |
Ames | 0.385 |
ROA | 0.55 |
SkinSen | 0.813 |
Carcinogencity | 0.382 |
EI | 0.945 |
Respiratory | 0.33 |
NR-Aromatase | 0.828 |
Antiviral | No |
Prediction | 0.909522 |